Chemed Co. (NYSE:CHE) CEO Sells $615,330.00 in Stock

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Chemed Stock Up 0.5 %

Shares of NYSE:CHE opened at $618.14 on Wednesday. The business’s 50 day moving average is $576.54 and its 200 day moving average is $567.29. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $639.61. The stock has a market cap of $9.05 billion, a price-to-earnings ratio of 31.23, a PEG ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio is 10.05%.

Institutional Trading of Chemed

Institutional investors and hedge funds have recently made changes to their positions in the company. Neuberger Berman Group LLC boosted its holdings in Chemed by 1.2% during the fourth quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company’s stock worth $265,726,000 after purchasing an additional 5,809 shares during the last quarter. State Street Corp boosted its stake in shares of Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock worth $279,063,000 after buying an additional 3,564 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Chemed by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 340,409 shares of the company’s stock valued at $180,654,000 after acquiring an additional 4,966 shares in the last quarter. FMR LLC increased its position in shares of Chemed by 18.9% during the fourth quarter. FMR LLC now owns 283,790 shares of the company’s stock valued at $150,352,000 after acquiring an additional 45,174 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Chemed by 8.2% during the fourth quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company’s stock worth $141,343,000 after acquiring an additional 20,310 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada upped their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.